Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

A multi-step continuous flow synthesis of pomalidomide

A multi-step continuous flow synthesis of pomalidomide The immunomodulatory drugs (IMiDs) thalidomide, pomalidomide, and lenalidomide are widely used to treat multiple myeloma. The permanent need of IMiDs analogues in clinical screening and practice has created the demand to find a reliable and robust method for their preparation. To reach this goal, the use of flow chemistry is quite appealing, allowing a safe operation, an excellent reproducibility and an efficient process. Herein, we describe a continuous 3–4 step flow approach for the synthesis of the pomalidomide (38–47% overall yield) and a few analogues.Graphical abstract[graphic not available: see fulltext] http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Flow Chemistry Springer Journals

A multi-step continuous flow synthesis of pomalidomide

Download PDF
5 pages

Loading next page...
 
/lp/springer-journals/a-multi-step-continuous-flow-synthesis-of-pomalidomide-R2rGywWSuU
Publisher
Springer Journals
Copyright
Copyright © Akadémiai Kiadó 2022
ISSN
2062-249X
eISSN
2063-0212
DOI
10.1007/s41981-022-00223-3
Publisher site
See Article on Publisher Site

Abstract

The immunomodulatory drugs (IMiDs) thalidomide, pomalidomide, and lenalidomide are widely used to treat multiple myeloma. The permanent need of IMiDs analogues in clinical screening and practice has created the demand to find a reliable and robust method for their preparation. To reach this goal, the use of flow chemistry is quite appealing, allowing a safe operation, an excellent reproducibility and an efficient process. Herein, we describe a continuous 3–4 step flow approach for the synthesis of the pomalidomide (38–47% overall yield) and a few analogues.Graphical abstract[graphic not available: see fulltext]

Journal

Journal of Flow Chemistry – Springer Journals

Published: Apr 19, 2022

Keywords: Active pharmaceutical ingredients; IMiDs; Thalidomide; Glutamine; Reduction

References

  • A short history of thalidomide Embryopathy
    Lenz, W
  • Clinical pharmacology of thalidomide
    Eriksson, T; Björkman, S; Höglund, P
  • Thalidomide and congenital abnormalities
    Mcbride, WG
  • Thalidomide and congenital abnormalities
    Speirs, AL
  • Enantioselective inhibition of TNF-α release by thalidomide and thalidomide-analogues
    Wnendt, S; Finkam, M; Winter, W; Ossig, J; Raabe, G; Zwingenberger, K
  • Stereospecific determination, chiral inversion in vitro and pharmacokinetics in humans of the enantiomers of thalidomide
    Eriksson, T; Bjöurkman, S; Roth, B; Fyge, Å; Höuglund, P
  • Amino-substituted thalidomide analogs: potent inhibitors of TNF-α production
    Muller, GW; Chen, R; Huang, S-Y; Corral, LG; Wong, LM; Patterson, RT; Chen, Y; Kaplan, G; Stirling, DI
  • Continuous flow reactors: a perspective
    Wiles, C; Watts, P
  • Continuous flow synthesis. A pharma perspective
    Malet-Sanz, L; Susanne, F
  • Development of a continuous flow synthesis of propranolol: tackling a competitive side reaction
    De Angelis, S; Celestini, P; Purgatorio, R; Degennaro, L; Rebuzzini, G; Luisi, R; Carlucci, C
  • Continuous flow synthesis of propofol
    Mougeot, R; Jubault, P; Legros, J; Poisson, T
  • Efficient synthesis of immunomodulatory drug analogues enables exploration of structure–degradation relationships
    Burslem, GM; Ottis, P; Jaime-Figueroa, S; Morgan, A; Cromm, PM; Toure, M; Crews, CM
  • Design, synthesis, and preliminary pharmacological evaluation of N-Acyl-3-Aminoglutarimides as broad-Spectrum chemokine inhibitors in vitro and anti-inflammatory agents in vivo
    Fox, DJ; Reckless, J; Warren, SG; Grainger, DJ
  • Effects of immunomodulatory derivatives of thalidomide (IMiDs) and their analogs on cell-differentiation, cyclooxygenase activity and angiogenesis
    Fujimoto, H; Noguchi, T; Kobayashi, H; Miyachi, H; Hashimoto, Y
  • Potent inhibition of tumor necrosis factor-α production by Tetrafluorothalidomide and Tetrafluorophthalimides
    Niwayama, S; Turk, BE; Liu, JO